![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Phase 1 Results for ATI-2173, a Novel Active Site
Polymerase Inhibitor Nucleotide (ASPIN), in HBV-Infected Subjects
|
|
|
EASL International Liver Congress, June 23-26, 2021 JNJ-3989
D. Mayers,1 A. Jucov,2,3 I. Anastasiy,3 N. Ghicavii,2 L. Ogilvie,1 K. Squires,1 A. De La Rosa1
1Antios Therapeutics, Atlanta, GA, USA; 2ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Republic of Moldova; 3Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova; 3ARENSIA Exploratory Medicine, Kiev, Ukraine
![0628211](../images/082521/062821-6/0628211.gif)
![0628212](../images/082521/062821-6/0628212.gif)
![0628213](../images/082521/062821-6/0628213.gif)
![0628214](../images/082521/062821-6/0628214.gif)
![0628215](../images/082521/062821-6/0628215.gif)
![0628216](../images/082521/062821-6/0628216.gif)
![0628217](../images/082521/062821-6/0628217.gif)
![0628218](../images/082521/062821-6/0628218.gif)
![0628219](../images/082521/062821-6/0628219.gif)
![06282110](../images/082521/062821-6/06282110.gif)
![06282111](../images/082521/062821-6/06282111.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|